The British government uses “Mongaro” needles to reduce obesity among its citizens.. What did tweeters say? | A mixture

These needles are called slimming needles, and the price of the needle starts at around $200, taken weekly, and could help you lose 20% of your body weight.

This medicine increases insulin production from the pancreas and reduces the amount of sugar produced by the liver. It then slows the rate at which food passes through the body, making the person feel full for longer.

An episode (10/16/2024) of the program “Shabakat” tracked the opinions of the British about the measure that their government is studying to reduce obesity.. So what did they say?

Kevin expressed his experience with these needles, saying, “I used Mongaro, and that was my decision because I was suffering from diabetes and high blood pressure, and it went my weight down within four months … I feel better than 10 years ago … and what this medicine will reduce in terms of health is worth this fatigue and it is also necessary. “

Jolie wrote that her partner “is using Ozambik needles because he is sick with BDiabetes “And the side effects are terrible, including suicidal thoughts above all. “

Craig commented on the matter by saying, “This is the excuse the Prime Minister is offering. He insults those who suffer from obesity and blames them because they cost the government a lot. Does he have morals or not? Even Boris Johnson wasn’t that tough.”

As for Leering, he asked, “Why don’t we try to make healthy food accessible to everyone? And let farmers grow crops.”

It should be noted that the British government agreed with the company “Lily” that makes the injection to test a quarter of a million British patients, and that they will inject it over time of 3 years.

The presenter of the program “Shabakat” says that needles alone will not be enough, and that they need a healthy lifestyle, such as exercise, limiting fast food and sugar consumption. He is also thinking.

Obesity causes a group of diseases that cost the British government more than $14 billion a year, as well as indirect economic damage such as sick leave.